Schonfeld Strategic Advisors LLC Protara Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.15 - $7.76 $147,323 - $185,890	-23,955 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$6.38 - $9.3 $3,190 - $4,650	-500 Reduced 2.04%	23,955 $166,000
Q2 2021 Aug 16, 2021	BUY	$8.68 - $16.99 $8,680 - $16,990	1,000 Added 4.26%	24,455 $238,000
Q1 2021 May 17, 2021	BUY	$13.75 - $23.86 $322,506 - $559,636	23,455 New	23,455 $371,000

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $25.8M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.